Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Take a closer look at HelloFresh, Bayer and Altech Advanced Materials

Bayer shares gained around 7 per cent last week. Is this the turnaround after the stock reached a multi-year low? Altech Advanced Materials stock is also working on an upward trend. The German battery hopeful has published a promising feasibility study. Their stationary s...
Fabian Lorenz | April 5, 2024 |

African Copper Project PEA Depicts 'One of the Largest Undeveloped Mines Worldwide'

The key points from this company's recently released study results and plan are presented in a BMO Capital Markets note. In a March 25 research report, analyst Andrew Mikitchook noted that Ivanhoe Mines Ltd.'s (IVN:TSX; IVPAF:OTCQX) newly released NI 43-101 technical ...
Streetwise Reports | April 1, 2019 |

A Company on a Mission to Revolutionize Mental Healthcare. Here’s How.

When Stockhouse Editorial last caught up with Cybin Inc. ( NEO.CYBN , NYSE: CYBIN , Forum ) back in October, our audience learned about a leading biotechnology company focused on researching and progressing psychedelic therapeutics by utilizing proprietary drug discover...
Dave Jackson | January 31, 2022 |

Buzz on the Bullboards: The Rebound Season?

As soon as American Thanksgiving passes, the mood in North American markets shifts dramatically. Investors start to contend with holidays, gifts, and vacations on one hand, and the end of their fiscal years on the other. Companies also look to end the calendar year on a po...
Omri Wallach | December 4, 2019 |

Defense Metals on track to build rare earth mine

Those who have worked in the business as long as I have will easily remember the rare earth mania of 2008-11. For about three years following China’s export restrictions on rare earth elements, which hiked the prices of REEs to record highs, the junior resour...
Richard (Rick) Mills | February 27, 2019 |

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson | November 6, 2023 |

Retrophin Shares Fall 30% on Failed Phase 3 FORT Study

Shares of Retrophin fell to a 52-week low on the news that topline results from its fosmetpantotenate Phase 3 FORT Study for PKNA treatment failed to meet expectations. Biopharmaceutical firm Retrophin Inc. (RTRX:NASDAQ) shares are trading much lower today as the co...
Streetwise Reports | August 26, 2019 |

How To De-Risk Investing in Junior Battery Metal Exploration Companies: Infographic & Case Study

How To De-Risk Investing in Junior Battery Metal Exploration Companies.
Research | October 3, 2022 |

Sangamo and Pfizer Report Positive Results for Hemophilia A Study

Sangamo Therapeutics and partner Pfizer reported positive results for phase 1/2 Alta study for hemophilia A at the International Society on Thrombosis and Hemostasis Congress in Melbourne, Australia. Sangamo Therapeutics Inc. (SGMO:NASDAQ) shares are up...
Streetwise Reports | July 9, 2019 |

Are Investors Blind To The Equities Upside Super Cycle?

Our research team believes the upside pricing potential of the US market could be under-estimated by global traders and investors. We've been pouring over the charts and data trying to substantiate our hypothesis with our proprietary price modeling systems and technical analys...
Chris Vermeulen | March 27, 2019 |
1 2 3 4 5 6 7 8 9 10 ...